The R22X Mutation of the SDHD Gene in Hereditary Paraganglioma Abolishes the Enzymatic Activity of Complex II in the Mitochondrial Respiratory Chain and Activates the Hypoxia Pathway
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Hereditary paragangliomas are usually benign tumors of the autonomic nervous system that are composed of cells derived from the primitive neural crest. Even though three genes (SDHD, SDHC, and SDHB), which encode three protein subunits of cytochrome b of complex II in the mitochondrial respiratory chain, have been identified, the molecular mechanisms leading to tumorigenesis are unknown. We studied a family in which the father and his eldest son had bilateral neck paragangliomas, whereas the second son had a left carotid-body paraganglioma and an ectopic mediastinal pheochromocytoma. A nonsense mutation (R22X) in the SDHD gene was found in these three affected subjects. Loss of heterozygosity was observed for the maternal chromosome 11q21-q25 within the tumor but not in peripheral leukocytes. Assessment of the activity of respiratory-chain enzymes showed a complete and selective loss of complex II enzymatic activity in the inherited pheochromocytoma, that was not detected in six sporadic pheochromocytomas. In situ hybridization and immunohistochemistry experiments showed a high level of expression of markers of the angiogenic pathway. Real-time quantitative reverse transcriptase (RT)-PCR measurements confirmed that vascular endothelial growth factor and endothelial PAS domain protein 1 mRNA levels were significantly higher (three- and sixfold, respectively) than those observed in three sporadic benign pheochromocytomas. Thus, inactivation of the SDHD gene in hereditary paraganglioma is associated with a complete loss of mitochondrial complex II activity and with a high expression of angiogenic factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These clinical observations and the finding of increased expression of HIF targets in tumors with SDH mutations [9,10] have suggested the possibility that the VHL and SDH syndromes intersect at the molecular level.”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mitochondrial complex II is a component of the electron transport chain, and mutations of SDHB or SDHD genes that abrogate the oxidoreductase function of complex II can cause pheochromocytomas [9,14,15].”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, patients harbouring mutations in SDH have increased HIF-1α activity23,24 and circulating succinate25.”
From Succinate is an inflammatory signal that induces IL-1β through HIF-1α (2013) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, mutations in subunit SdhB, SdhC, or SdhD are linked to tumorigenesis in the form of autosome-dominant familial paragangliomas and pheochromocytomas (1, 3, 16, 19, 33).”
From Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis (2008) · cites this paper as [19]
In the citing paper
“A relationship between SDH function and oxygen regulation has been suspected based on previous identification of increased expression of angiogenic factors in cases of SDH-mutant pheochromocytomas [9].”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions
Higuchi, R., Fockler, C., Dollinger, G., & Watson, R. (1993) · Nature Biotechnology · doi:10.1038/nbt0993-1026 · Cited by 2,159 · cited 1×
“Relative quantitation of EPAS1 and VEGF gene expression was analyzed as a target-to-control expression ratio, using the standard curve method (Higuchi et al, 1993).”
MethodMitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926 · cited 2×
“Mitochondria can act as O2 sensors by increasing the generation of reactive oxygen species, which are required for hypoxia-inducible factor 1 DNA–binding activity and subsequent increases in the synthesis of mRNA that encodes erythropoietin, vascular endothelial growth factor (VEGF), and glycolytic enzymes (Chandel et…”
BackgroundMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 6×
“The four exons of the SDHD gene (GenBank accession number AB 026906) were am- plified by PCR with primers and a procedure that has been described elsewhere (Baysal et al. 2000).”
BackgroundMethodInfluentialOxidative Phosphorylation at the fin de siècle
Saraste, M. (1999) · Science · doi:10.1126/science.283.5407.1488 · Cited by 1,313 · cited 2×
“Complex II or succinate-ubiquinone reductase (EC 1.3.99.1) is an important enzymatic complex crucial for both the tricarboxylic acid cycle and the aerobic respiratory chains of mitochondria (Saraste 1999).”
BackgroundInfluentialBiochemical and molecular investigations in respiratory chain deficiencies
Rustin, P., Chretien, D., Bourgeron, T., Gérard, B., Rötig, A., Saudubray, J. M., & Munnich, A. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90055-8 · Cited by 1,243 · cited 1×
“The activity of the respiratory-chain complexes was measured, as described elsewhere (Rustin et al. 1994).”
MethodSelf-citationAstuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087 · cited 2×
“Then, several germline SDHD mutations were reported in families with paraganglioma (Badenhop et al. 2001; Milunsky et al. 2001) and in families with pheochromocytoma (Astuti et al. 2001a).”
BackgroundMutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875 · cited 2×
“The SDHC gene encoding the large subunit of cytochrome b in succinate-ubiquinone oxidoreductase was reported to correspond to the PGL3 gene (Niemann and Müller 2000; Niemann et al. 2001).”
BackgroundDifferential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes
Gerber, H.-P., Condorelli, F., Park, J., & Ferrara, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23659 · Cited by 794 · cited 1×
“First, VEGF-R1 mRNA, which encodes the VEGF receptor induced in hypoxic conditions (Gerber et al. 1997), was found to be more abundant than VEGF-R2 mRNA.”
BackgroundBourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730 · cited 1×
“The causative mutation was identified in the SDHA gene encoding the flavoprotein of complex II, and the enzymatic defect was partial (Bourgeron et al. 1995).”
BackgroundSelf-citationNeurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells
SCHMECHEL, D., MARANGOS, P. J., & BRIGHTMAN, M. (1978) · Nature · doi:10.1038/276834a0 · Cited by 723 · cited 1×
“This result was expected, because NSE is considered an indicator of neuroendocrine differentiation (Schmechel et al. 1978).”
Background
Research works printed but not linked: 2
- Koreth, 1999, Chromosomes, 11q and cancer: a review, J Pathol, 187, 28, 10.1002/(SICI)1096-9896(199901)187:1<28::AID-PATH166>3.0.CO;2-R · doi:10.1002/(sici)1096-9896(199901)187:1<28::aid-path166>3.0.co;2-r
- Pacheco-Ojeda, 1988, Carotid body at high altitudes, World J Surg, 12, 856
Cited by
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
“Similarly, SDHB and SDHD mutations can cause pheochromocytoma (Astuti et al., 2001; Gimm et al., 2000), and mutations in FH cause a dominant syndrome of uterine fibroids, leiomyomata, and papillary renal cell cancer (Tomlinson et al.”
BackgroundSuccinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108
“…(HIF-1 (cid:1) ) in nuclei and the induction of hypoxia-inducible genes were observed in paragangli-to human HIF-1 (cid:1) ) enables formation of two hydrogen bonds to pVHL and increases the binding of pVHL to HIF-(cid:1) by several oma carrying an SDHD mutation (Gimenez-Roqueplo et al., 2001).”
BackgroundMitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Sabharwal, S. S., & Schumacker, P. T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3803 · Cited by 1,622
Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958
Role of VHL Gene Mutation in Human Cancer
Kim, W. Y., & Kaelin, W. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.061 · Cited by 943
Neumann, H. P. H. (2004) · JAMA · doi:10.1001/jama.292.8.943 · Cited by 893
“Abdominal extra-adrenal 16 50 (32-68) 7 21 (8-38) .”
Pollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi227 · Cited by 865
“Four tumours (three paragangliomas and one extra-adrenal phaeochromocytoma) from a family with an SDHD R22X mutation showed expression of vascular endothelial growth factor (VEGF ) and endothelial PAS domain protein 1 (EPAS1/HIF2a) mRNAs at higher levels than that in sporadic phaeochromocytomas (24).”
BackgroundSelf-citationSDH mutations establish a hypermethylator phenotype in paraganglioma
Letouzé, E., Martinelli, C., Loriot, C., Burnichon, N., Abermil, N., Ottolenghi, C., Janin, M., Menara, M., Nguyen, A. T., Benit, P., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.018 · Cited by 776
Self-citationGenetic Testing in Pheochromocytoma or Functional Paraganglioma
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 684
Self-citationSuccinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
King, A., Selak, M. A., & Gottlieb, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209594 · Cited by 672
“This is supported by the observation that mutations in either SDHB or SDHD result in the disintegration of the SDH complex and a complete loss of SDH enzymatic activity (Gimenez-Roqueplo et al., 2001; Gimenez-Roqueplo et al., 2002; Douwes Dekker et al., 2003).”
BackgroundJaneway, K. A., Kim, S. Y., Lodish, M., Nosé, V., Rustin, P., Gaal, J., Dahia, P. L. M., Liegl, B., Ball, E. R., Raygada, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009199108 · Cited by 628
Self-citationClinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes
Benn, D. E., Gimenez-Roqueplo, A.-P., Reilly, J. R., Bertherat, J., Burgess, J., Byth, K., Croxson, M., Dahia, P. L. M., Elston, M., Gimm, O., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1862 · Cited by 570
“P, Pheochromocytoma of adrenal gland; A, abdominal extraadrenal paraganglioma (pheochromocytoma); T, thoracic extraadrenal paraganglioma (pheochromocytoma); H, head and neck paraganglioma; (M), metastases. a Previously published case ( 9 ).”
BackgroundSelf-citationMutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaître, X. (2003) · PubMed · Cited by 609
Self-citationSuccinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis
Tretter, L., Patocs, A., & Chinopoulos, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.03.012 · Cited by 539
van Nederveen, F. H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R. A., de Bruyn, E. M., Sleddens, H. F., Derkx, P., Rivière, J., Dannenberg, H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70164-0 · Cited by 538
Self-citationLee, S., Nakamura, E., Yang, H., Wei, W., Linggi, M. S., Sajan, M. P., Farese, R. V., Freeman, R. S., Carter, B. D., Kaelin, W. G., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.015 · Cited by 527
Inhibition of Hypoxia-inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates
Koivunen, P., Hirsilä, M., Remes, A. M., Hassinen, I. E., Kivirikko, K. I., & Myllyharju, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610415200 · Cited by 521
What good is genomic imprinting: the function of parent-specific gene expression
Wilkins, J. F., & Haig, D. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1062 · Cited by 490
A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
Dahia, P. L. M., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010008 · Cited by 443
“SDH mutations [9,10] have suggested the possibility that the”
Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S., & Schumacker, P. T. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01338-07 · Cited by 427
“These observations suggest that defects in SdhB, SdhC, or SdhD, but not SdhA, lead to an abnormal activation of hypoxia-inducible factor 1 (HIF-1 ), which regulates the expression of vascular mitogens, including vascular endothelial growth factor (VEGF) (19, 46).”
BackgroundInfluentialAltered metabolite levels in cancer: implications for tumour biology and cancer therapy
Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.85 · Cited by 406
Oncometabolites: linking altered metabolism with cancer
Yang, M., Soga, T., & Pollard, P. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67228 · Cited by 422
Puisségur, M.-P., Mazure, N. M., Bertero, T., Pradelli, L., Grosso, S., Robbe-Sermesant, K., Maurin, T., Lebrigand, K., Cardinaud, B., Hofman, V, et al. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.119 · Cited by 423
“miR-210 positively regulates HIF-1 α activity As mutations in SDH subunits have been shown to activate HIF-1”
BackgroundBardella, C., Pollard, P. J., & Tomlinson, I. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.07.003 · Cited by 395
A role for mitochondrial enzymes in inherited neoplasia and beyond
Eng, C., Kiuru, M., Fernandez, M. J., & Aaltonen, L. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1013 · Cited by 392
Burnichon, N., Rohmer, V., Amar, L., Herman, P., Leboulleux, S., Darrouzet, V., Niccoli, P., Gaillard, D., Chabrier, G., Chabolle, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2504 · Cited by 378
“When frozen tumor tissues were available, we: 1) searched for exon skipping in cDNA for unknown variants located in splice sites (after extraction of tumor RNA and RTPCR); 2) tested for loss of heterozygosity at the SDH locus using tumoral and peripheral DNA and microsatellite markers as described elsewhere (14, 15);…”
MethodSelf-citationMacKenzie, E. D., Selak, M. A., Tennant, D. A., Payne, L. J., Crosby, S., Frederiksen, C. M., Watson, D. G., & Gottlieb, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01927-06 · Cited by 359
“Pseudohypoxia was also shown recently in tumor cells with mutations in fumarate hydratase (FH) or in any of three of the four subunits of succinate dehydrogenase (SDH), SDHB, SDHC, or SDHD (5, 8 , 9, 19, 20, 28).”
BackgroundMiettinen, M., Wang, Z.-F., Sarlomo-Rikala, M., Osuch, C., Rutkowski, P., & Lasota, J. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182260752 · Cited by 363
“Similar gene expression profiles reported in CT, CSS, pediatric GISTs, and a small number of adult GISTs also seem to support the unifying concept of SDH-deficient GIST.1 SDHB-deficient GISTs seem to exclusively occur in the stomach, and none of the GISTs from other locations were SDHB negative.”
BackgroundInfluentialGenetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
Welander, J., Söderkvist, P., & Gimm, O. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0170 · Cited by 355
“…regardless of whether its gene product has catalytic or anchorage function, have been demonstrated to cause an abolishment of SDH enzyme activity (Gimenez-Roqueplo et al. 2001, Douwes Dekker et al. 2003) as well as an absence of SDHB protein expression (van Nederveen et al. 2009, Gill et al.…”
BackgroundRicketts, C. J., Forman, J. R., Rattenberry, E., Bradshaw, N., Lalloo, F., Izatt, L., Cole, T. R., Armstrong, R., Kumar, V. K. A., Morrison, P. J., et al. (2010) · Human Mutation · doi:10.1002/humu.21136 · Cited by 337
Chen, J.-Q., & Russo, J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.06.004 · Cited by 327
The Redox Basis of Epigenetic Modifications: From Mechanisms to Functional Consequences
Cyr, A. R., & Domann, F. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3492 · Cited by 297
Gill, A. J., Benn, D. E., Chou, A., Clarkson, A., Muljono, A., Meyer-Rochow, G. Y., Richardson, A. L., Sidhu, S. B., Robinson, B. G., & Clifton-Bligh, R. J. (2010) · Human Pathology · doi:10.1016/j.humpath.2009.12.005 · Cited by 277
The NGS in PPGL (NGSnPPGL) Study Group, Toledo, R. A., Burnichon, N., Cascon, A., Benn, D. E., Bayley, J.-P., Welander, J., Tops, C. M., Firth, H., Dwight, T., et al. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.185 · Cited by 275
Self-citationPasini, B., & Stratakis, C. A. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02111.x · Cited by 273
“Gimenez-Roqueplo and colleagues [78] first studied the biological effect of a loss of function SDHD germline mutation (p.Arg22X): a complete loss of the maternal wt allele was found in the related extra-adrenal PGL of the mediastinum where both functions of SDH were completely abolished, i.e. the…”
Miyadera, H., Shiomi, K., Ui, H., Yamaguchi, Y., Masuma, R., Tomoda, H., Miyoshi, H., Osanai, A., Kita, K., & Ōmura, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237315100 · Cited by 256
Mitochondria in cancer: Not just innocent bystanders
Frezza, C., & Gottlieb, E. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.008 · Cited by 268
The Mitochondrial Chaperone TRAP1 Promotes Neoplastic Growth by Inhibiting Succinate Dehydrogenase
Sciacovelli, M., Guzzo, G., Morello, V., Frezza, C., Zheng, L., Nannini, N., Calabrese, F., Laudiero, G., Esposito, F., Landriscina, M., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.019 · Cited by 264
Pathania, D., Millard, M., & Neamati, N. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.010 · Cited by 263
Succinate dehydrogenase and human diseases: new insights into a well-known enzyme
Rustin, P., Munnich, A., & Rötig, A. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200793 · Cited by 257
Self-citationBenchoua, A., Trioulier, Y., Zala, D., Gaillard, M.-C., Lefort, N., Dufour, N., Saudou, F., Elalouf, J.-M., Hirsch, E., Hantraye, P., et al. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0607 · Cited by 248
“The viruses were resuspended in phosphate-buffered saline (PBS) with 1% BSA and matched for particle concentration after measuring of p24 antigen content.”
MethodInfluentialClassification of mitocans, anti-cancer drugs acting on mitochondria
Neuzil, J., Dong, L.-F., Rohlena, J., Truksa, J., & Ralph, S. J. (2013) · Mitochondrion · doi:10.1016/j.mito.2012.07.112 · Cited by 245
Hereditary paraganglioma targets diverse paraganglia: Table 1
Baysal, B. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.9.617 · Cited by 235
2-Oxoglutarate-dependent dioxygenases in cancer
Losman, J.-A., Koivunen, P., & Kaelin, W. G. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-00303-3 · Cited by 230
Lussey-Lepoutre, C., Hollinshead, K. E. R., Ludwig, C., Menara, M., Morin, A., Castro-Vega, L.-J., Parker, S. J., Janin, M., Martinelli, C., Ottolenghi, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9784 · Cited by 227
“…arising from such mutations demonstrate stabilization and activation of the hypoxia-inducible transcription factors, HIF1 and 2, which have been shown to elicit hypoxia-like alterations in metabolism, such as increased lactate dehydrogenase A (LDHA) expression and lactate production 8,9,17,18 .”
Self-citationMetabolic transformation in cancer
Tennant, D. A., Duran, R. V., Boulahbel, H., & Gottlieb, E. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp070 · Cited by 225
Is cancer a disease of abnormal cellular metabolism? New angles on an old idea
Deberardinis, R. J. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31818b0d9b · Cited by 219
Hypoxia/pseudohypoxia‐mediated activation of hypoxia‐inducible factor‐1α in cancer
Hayashi, Y., Yokota, A., Harada, H., & Huang, G. (2019) · Cancer Science · doi:10.1111/cas.13990 · Cited by 216
Regulation of succinate dehydrogenase and role of succinate in cancer
Dalla Pozza, E., Dando, I., Pacchiana, R., Liboi, E., Scupoli, M. T., Donadelli, M., & Palmieri, M. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.04.013 · Cited by 212
Functional Consequences of a SDHB Gene Mutation in an Apparently Sporadic Pheochromocytoma
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Rieubland, C., Kerlan, V., Plouin, P.-F., Rötig, A., & Jeunemaitre, X. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020525 · Cited by 209
“The expression of five genes (EPAS1, VEGF, VEGFR-1, VEGFR-2, and neuron-specific enolase) encoding angiogenic and hypoxia-induced factors was studied in SDHB-mutated pheochromocytoma tissue by immunohistochemistry and in situ hybridization with procedures previously described (5, 9).”
BackgroundMethodSelf-citationPugh, C. W., & Ratcliffe, P. J. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00103-7 · Cited by 201
15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5
Benn, D. E., Robinson, B. G., & Clifton-Bligh, R. J. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0268 · Cited by 197
“…a surrogate marker for SDH deficiency and provides functional validation of pathogenic SDHx mutations SDHx are tumour suppressor genes: inheritance of a pathogenic mutation on one allele in the germline is typically accompanied by loss of the normal allele in tumours (Gimenez-Roqueplo et al. 2001).”
BackgroundAstrom, K., Cohen, J. E., Willett-Brozick, J. E., Aston, C. E., & Baysal, B. E. (2003) · Human Genetics · doi:10.1007/s00439-003-0969-6 · Cited by 187
“Together, these three studies describe 83 “unrelated” PGL1 families and subjects attributable to three founder mutations in the central and western parts of The Netherlands, in stark contrast to the 25 distinct SDHD mutations (reviewed in Baysal 2002) reported thus far among 43 independent familial and nonfamilial cas…”
BackgroundInfluentialCurrent and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma
Jimenez, C., Rohren, E., Habra, M. A., Rich, T., Jimenez, P., Ayala-Ramirez, M., & Baudin, E. (2013) · Current Oncology Reports · doi:10.1007/s11912-013-0320-x · Cited by 178
“Inactivation of the SDHB gene allows activation of hypoxia-inducible target genes such as hypoxia-inducible factor 2-alpha (HIF-2alpha) [80, 81].”
BackgroundPollard, P. J., Spencer-Dene, B., Shukla, D., Howarth, K., Nye, E., El-Bahrawy, M., Deheragoda, M., Joannou, M., McDonald, S., Martin, A., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.005 · Cited by 178
The pressure rises: update on the genetics of phaeochromocytoma
Maher, E. R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2347 · Cited by 176
Pheochromocytoma and functional paraganglioma syndrome: No longer the 10% tumor
Elder, E. E., Elder, G., & Larsson, C. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20177 · Cited by 173
“Inactivation of the SDHD gene is associated with high expression of angiogenic factors such as VEGF [45], mediated by activation of hypoxia-inducible factor-1 (HIF-1).”
BackgroundHypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction
Jochmanova, I., Yang, C., Zhuang, Z., & Pacak, K. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt201 · Cited by 172
“(136,140) described overexpression of HIF-2α and VEGF in patients with PHEOs and PGLs carrying SDHB and SDHD mutations compared with sporadic PHEOs and PGLs.”
BackgroundMitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages
Dowling, J. K., Afzal, R., Gearing, L. J., Cervantes-Silva, M. P., Annett, S., Davis, G. M., De Santi, C., Assmann, N., Dettmer, K., Gough, D. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21617-2 · Cited by 170
Succinate inhibition of α-ketoglutarate-dependent enzymes in a yeast model of paraganglioma
Smith, E. H., Janknecht, R., & Maher, L. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm275 · Cited by 169
Bayley, J.-P., Launonen, V., & Tomlinson, I. P. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-20 · Cited by 162
“HIF1α targets, including vascular endothelial growth factor (VEGF), erythropoietin (EPO), and glucose transporter1 (GLUT1), show activation on accumulation of TCA metabolites, and contribute to an increase in microvessel density [18,20,22-26].”
BackgroundTCA Cycle Defects and Cancer: When Metabolism Tunes Redox State
Cardaci, S., & Ciriolo, M. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/161837 · Cited by 161
Kaelin, W. G. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010975 · Cited by 161
“…is also suspected of playing a pathogenic role in papillary renal carcinomas linked to FH deficiency and to paragangliomas linked to SDH defi- ciency (Gimenez-Roqueplo et al. 2001; Isaacs et al. 2005; Pollard et al. 2005; Selak et al. 2005, 2006; MacKenzie et al. 2007; Pollard et al. 2007;…”
The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase
Pollard, P., Wortham, N., & Tomlinson, I. (2003) · Annals of Medicine · doi:10.1080/07853890310018458 · Cited by 159
Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells
Cervera, A. M., Bayley, J.-P., Devilee, P., & McCreath, K. J. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-89 · Cited by 156
“Although the mechanism(s) linking SDH deficiency to tumour formation remain poorly understood, an activation of the hypoxia pathway is frequently associated with SDH loss of function [6,7].”
BackgroundBrière, J.-J., Favier, J., Bénit, P., Ghouzzi, V. E., Lorenzato, A., Rabier, D., Di Renzo, M. F., Gimenez-Roqueplo, A.-P., & Rustin, P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi359 · Cited by 152
“The expression of the two SDHA forms in PGs , established in our study , presumably prohibits succinate accumulation in this tissue in the case of a SDHA mutation .”
BackgroundInfluentialSelf-citationPiruat, J. I., Pintado, C. O., Ortega-Sáenz, P., Roche, M., & López-Barneo, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10933-10940.2004 · Cited by 150
Oncometabolites‐driven tumorigenesis: From genetics to targeted therapy
Morin, A., Letouzé, É., Gimenez‐Roqueplo, A., & Favier, J. (2014) · International Journal of Cancer · doi:10.1002/ijc.29080 · Cited by 173
“We further demonstrated that the abundance of both hypoxia-inducible factor-2a (HIF-2a) and vascular endothelial growth factor (VEGF) was higher in tumors from SDHx mutation carriers than in tumors from patients without these mutations.(22,23) HIF-1 and HIF-2 are the main transcription factors involved in cellular and…”
BackgroundSelf-citationInborn and acquired metabolic defects in cancer
Frezza, C., Pollard, P. J., & Gottlieb, E. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0728-4 · Cited by 146
“The observation that tumors derived from SDH or FH mutations are genetically and histologically characterized by a strong hypoxic signature and are significantly more vascularized [28–30] suggested a causal link between TCA cycle dysfunctions and the activation of the hypoxiainducible transcription factors (HIFs), mas…”
BackgroundPhaeochromocytoma, new genes and screening strategies
Gimenez‐Roqueplo, A., Lehnert, H., Mannelli, M., Neumann, H., Opocher, G., Maher, E. R., Plouin, P., & on behalf of the European Network for the Study of Adrenal Tumours (ENS@T) Pheochromocytoma Working Group (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02714.x · Cited by 145
Self-citationLópez‐Barneo, J., Ortega‐Sáenz, P., Pardal, R., Pascual, A., & Piruat, J. I. (2008) · European Respiratory Journal · doi:10.1183/09031936.00056408 · Cited by 163
Pollard, P. J., El-Bahrawy, M., Poulsom, R., Elia, G., Killick, P., Kelly, G., Hunt, T., Jeffery, R., Seedhar, P., Barwell, J., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0920 · Cited by 139
The role of complex II in disease
Hoekstra, A. S., & Bayley, J. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.11.005 · Cited by 154
In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas
Toledo, R. A., Qin, Y., Srikantan, S., Morales, N. P., Li, Q., Deng, Y., Kim, S.-W., Pereira, M. A. A., Toledo, S. P. A., Su, X., et al. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-13-0101 · Cited by 134
“Loss-of-function mutations in these genes lead to increased stability of main components of the response to low oxygen levels, the hypoxia-inducible factor (HIF) proteins (Gimenez-Roqueplo et al. 2001, Dahia et al. 2005).”
BackgroundClinical aspects of SDHx-related pheochromocytoma and paraganglioma
Timmers, H. J. L. M., Gimenez-Roqueplo, A.-P., Mannelli, M., & Pacak, K. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-08-0284 · Cited by 131
Self-citationZhang, J., Yao, M., Xia, S., Zeng, F., & Liu, Q. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00682-7 · Cited by 126
Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease
Eckert, G. P., Renner, K., Eckert, S. H., Eckmann, J., Hagl, S., Abdel-Kader, R. M., Kurz, C., Leuner, K., & Muller, W. E. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8271-z · Cited by 134
Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight
Al‐Khallaf, H. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0165-3 · Cited by 152
Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer?
Lemarié, A., & Grimm, S. (2011) · Oncogene · doi:10.1038/onc.2011.167 · Cited by 140
Effects of Polyphenols on Brain Ageing and Alzheimer’s Disease: Focus on Mitochondria
Schaffer, S., Asseburg, H., Kuntz, S., Muller, W. E., & Eckert, G. P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8282-9 · Cited by 131
Pheochromocytomas: The (pseudo)-hypoxia hypothesis
Favier, J., & Gimenez‐Roqueplo, A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.004 · Cited by 124
Self-citationTricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation
Brière, J.-J., Favier, J., Gimenez-Roqueplo, A.-P., & Rustin, P. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00216.2006 · Cited by 109
“They result from a germline heterozygous mutation associated with a loss of the wild type allele in the tumoral tissue, inducing a specific loss of SDH enzymatic activity (23).”
BackgroundSelf-citationOn the association of succinate dehydrogenase mutations with hereditary paraganglioma
Baysal, B. E. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.08.004 · Cited by 106
Astuti, D., Hart‐Holden, N., Latif, F., Lalloo, F. I., Black, G. C. M., Lim, C., Moran, A., Grossman, A. B., Hodgson, S. V., Freemont, A. J., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01914.x · Cited by 112
“…reports of germline SDHB and SDHD mutations in familial phaeochromocytoma kindreds, others have reported similar findings in familial and isolated cases (Gimm et al., 2000; Astuti et al., 2001a, 2001b; Gimenez-Roqueplo et al., 2001; Cascon et al., 2002; Neumann HP et al., 2002; Young et al., 2002).”
ResultTumors of the neural crest: Common themes in development and cancer
Maguire, L. H., Thomas, A. R., & Goldstein, A. M. (2014) · Developmental Dynamics · doi:10.1002/dvdy.24226 · Cited by 119
SDH-related pheochromocytoma and paraganglioma
Kantorovich, V., King, K. S., & Pacák, K. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.04.001 · Cited by 113
Exploring cancer metabolism using stable isotope-resolved metabolomics (SIRM)
Bruntz, R. C., Lane, A. N., Higashi, R. M., & Fan, T. W. ‐. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.776054 · Cited by 114
The contribution of mitochondria to common disorders
Enns, G. M. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.08.009 · Cited by 112
Pollard, P., Wortham, N., Barclay, E., Alam, A., Elia, G., Manek, S., Poulsom, R., & Tomlinson, I. (2005) · The Journal of Pathology · doi:10.1002/path.1686 · Cited by 100
“Recently, evidence has been produced to show that tumours from HPGL have an activated hypoxia pathway [16].”
BackgroundCancer-derived extracellular succinate: a driver of cancer metastasis
Kuo, C.-C., Wu, J.-Y., & Wu, K. K. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00878-z · Cited by 125
Cells Silenced for SDHB Expression Display Characteristic Features of the Tumor Phenotype
Cervera, A. M., Apostolova, N., Crespo, F. L., Mata, M., & McCreath, K. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5580 · Cited by 98
“Genetic analysis of a hereditary paraganglioma, which was traced to an inactivating mutation of SDHD, revealed an association between mutations in SDH and activation of the hypoxia-response pathway ( 7 ).”
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia
Toledo, R. A., Jiménez, C., Armaiz-Peña, G., Arenillas, C., Capdevila, J., & Dahia, P. L. M. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac025 · Cited by 114
Pheochromocytomas and secreting paragangliomas
Plouin, P., & Gimenez‐Roqueplo, A. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-49 · Cited by 105
“In hereditary cases with germline SDHD or SDHB mutations, the tumors exhibit loss of the remaining wild-type allele with complete inhibition of complex II electron transfer activity, leading to activation of pro-angiogenic hypoxic-inducible transcription factors (HIFs) [9-11].”
BackgroundSelf-citationGenetic insights into familial cancers – update and recent discoveries
Marsh, D. J., & Zori, R. T. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00023-x · Cited by 114
Douwes Dekker, P., Hogendoorn, P., Kuipers‐Dijkshoorn, N., Prins, F., van Duinen, S., Taschner, P., van der Mey, A., & Cornelisse, C. (2003) · The Journal of Pathology · doi:10.1002/path.1461 · Cited by 94
“Possibly a hypoxia pathway is triggered through activation of hypoxia inducible factor-I (HIFI) and downstream targets such as vascular endothelial growth factor (VEGF) [14,15,30].”
BackgroundThe genetics of paragangliomas: a review
Martin, T., Irving, R. M., & Maher, E. R. (2007) · Clinical Otolaryngology · doi:10.1111/j.1365-2273.2007.01378.x · Cited by 103
Rare insights into cancer biology
Adam, J., Yang, M., Soga, T., & Pollard, P. J. (2013) · Oncogene · doi:10.1038/onc.2013.222 · Cited by 92
SDHi fungicides: An example of mitotoxic pesticides targeting the succinate dehydrogenase complex
Tête, A., Debizet, K., Imler, J., Tomkiewicz, C., Blanc, É., Barouki, R., Coumoul, X., & Bortoli, S. (2023) · Environment International · doi:10.1016/j.envint.2023.108219 · Cited by 106
Hereditary Paraganglioma/Pheochromocytoma and Inherited Succinate Dehydrogenase Deficiency
Favier, J., Brière, J.-J., Strompf, L., Amar, L., Filali, M., Jeunemaitre, X., Rustin, P., & Gimenez-Roqueplo, A.-P. (2005) · Hormone Research in Paediatrics · doi:10.1159/000084685 · Cited by 88
“Such tests should be carried out annually for patients with SDHB mutations and every 2 years for patients with SDHD mutations. It is important to note that all these guidelines are empiric and require validation by prospective studies in families with SDH mutations. SDH Genes and Tumorigenesis SDH genes ( SDHD , SDHC…”
BackgroundSelf-citation
Metadata
- Authors
- Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Mourad, J.-J., Plouin, P.-F., Corvol, P., Rötig, A., & Jeunemaitre, X.
- Affiliations
- Inserm (FR)
- Hôpital Saint-Michel (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2001-12
- Volume
- 69
- Issue
- 6
- Pages
- 1186-1197
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1235531
- OpenAlex
- W1975918337
- Cited by
- 364
- References
- 44
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 12 · 2022: 8 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 9 · 2017: 12 · 2016: 15 · 2015: 14 · 2014: 32 · 2013: 24 · 2012: 19
- FWCI
- 14.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4248 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- hereditary paraganglioma, succinate dehydrogenase, cytochrome b, mitochondrial respiratory chain, loss of heterozygosity, pheochromocytoma, carotid body paraganglioma, hypoxia pathway, angiogenic factors, vascular endothelial growth factor, EPAS1, tumor angiogenesis, SDHC, SDHB
- MeSH terms
- Adult, Aged, Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 11, Consanguinity, Electron Transport, Female, Humans, Immunohistochemistry, Male, Middle Aged, Mitochondria, Oxygen, Paraganglioma, Pedigree, RNA, Messenger, Succinate Dehydrogenase, Cell Hypoxia, Gene Expression, In Situ Hybridization, Germ-Line Mutation, Codon, Nonsense, Loss of Heterozygosity, Reverse Transcriptase Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.